Daclatasvir + asunaprevir + beclabuvir ± ribavirin for chronic <scp>HCV</scp> genotype 1‐infected treatment‐naive patientsGregory T. Everson, David Gardiner, Tarek Hassanein et al.|Liver International|2015Cited by 26
Pretreatment and on-treatment ctDNA and tissue biomarkers predict recurrence in patients with stage IIIB–D/IV melanoma treated with adjuvant immunotherapy: CheckMate 915Georgina V. Long, Jeffrey S. Weber, Hao Tang et al.|Journal for ImmunoTherapy of Cancer|2025Cited by 11